Optimisation of blood glucose management is important for all patients with type 2 diabetes to improve both short-term and long-term health outcomes. General glycaemic targets have therefore been set for newly-diagnosed patients with uncomplicated diabetes at an HbA1c = 7% (53mmol/mol). Despite these guidelines for glycaemic management, however, over 60% of patients are reported as not reaching their glycaemic goals. One Australian study showed less than half of all patients with type 2 diabetes seen in general practice had an HbA1c = 7% (53 mmol/mol) while 25% had an HbA1c > 8% (64mmol/mol).
This interactive online learning activity is valued at 2 Hour(s) of continuing education.
Associate Professor Michael d'Emden
MBBS, PhD, FRACP
Director of Endocrinology and Diabetes
Royal Brisbane Hospital
MBBS, MWell, DipRACOG
South Coast Medical
Blairgowrie, Victoria, Australia
On completion of this program, participants will be better able to:
- Review the patient-mediated barriers to initiation of insulin and titration of insulin doses and methods to help the patient overcome them
- Identify patients who might benefit from earlier insulinisation with a long-acting basal insulin to help reach their individualised treatment goals
- Implement simple dose titration strategies with patients to attain a maintenance dose that will facilitate good glycaemic management while minimising hypoglycaemic episodes
- Identify patients who would benefit from referral to a Credentialled Diabetes Educator (CDE) and familiarise themselves with referral mechanisms to CDEs